Acorda Therapeutics Inc.

NASDAQ: ACOR · Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM

Acorda Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
9.36M 30.36M 32.47M 25.27M 30.25M 37.54M 20.7M 23.13M 31.87M 45.63M 36.17M 45.71M 116.77M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a 255K 255K 255K 510K 255K 255K 255K n/a n/a n/a n/a n/a
Other Long-Term Assets
4.95M 4.19M 3.9M 3.15M 2.01M -42.78M 502K 503K 6.2M 6.2M 12.41M 12.41M 18.62M
Receivables
9.19M 17.3M 11.98M 13.39M 9.19M 13.87M 14.69M 14.27M 11.99M 17M 13.59M 14.01M 17.3M
Inventory
14.12M 16.16M 17.94M 14.8M 13.46M 12.75M 15.25M 15.32M 14.84M 18.55M 20.59M 25.36M 27.41M
Other Current Assets
2.45M 10.98M 10.48M 10.63M 4.07M 11.08M 7.82M 10.69M 1.86M 7.57M 13.37M 14.98M 15.18M
Total Current Assets
48.45M 74.79M 73.73M 64.91M 68.09M 82.11M 71.69M 76.52M 80.45M 102.16M 97.07M 112.94M 189.72M
Property-Plant & Equipment
5.83M 6.3M 6.71M 6.93M 7.41M 7.89M 8.37M 8.81M 9.26M 11.13M 12.88M 14.66M 16.46M
Goodwill & Intangibles
22.34M 22.99M 282.01M 289.7M 297.39M 305.09M 312.78M 320.47M 328.23M 335.98M 343.73M 351.48M 359.25M
Total Long-Term Assets
33.12M 42.95M 292.62M 299.78M 306.81M 313.48M 321.65M 329.79M 343.68M 353.31M 369.02M 378.56M 394.33M
Total Assets
81.58M 117.75M 366.34M 364.7M 374.91M 395.6M 393.34M 406.31M 424.14M 455.47M 466.09M 491.5M 584.05M
Account Payables
9.93M 13.37M 12.33M 3.17M 2.85M 10.09M 11.51M 7.96M 8.77M 11.81M 15.5M 17.48M 9.49M
Deferred Revenue
294K 227K 465K 548K n/a 384K n/a n/a n/a 27.64M 34.16M 28.81M 38.12M
Short-Term Debt
193.07M 187.73M 1.58M 1.57M 1.56M 1.54M 1.45M 1.35M 7.04M 8.19M 9.32M 10.71M 74.73M
Other Current Liabilities
20.64M 26.44M 31.92M 25.1M 30.33M 25.93M 29.06M 31.82M 30.2M 6.39M 9.3M 10.66M 10.71M
Total Current Liabilities
223.94M 227.77M 46.29M 30.39M 34.74M 37.95M 42.02M 41.12M 46M 54.02M 68.27M 68.27M 133.05M
Long-Term Debt
2.85M 3.17M 184.51M 179.93M 175.55M 171.37M 192.3M 189.87M 186.31M 182.76M 179.66M 176.37M 178.18M
Other Long-Term Liabilities
40.56M 35.54M 38.04M 46.96M 45.85M 48.45M 41.02M 46.6M 50.09M 53.59M 41.44M 41.88M 49.62M
Total Long-Term Liabilities
43.41M 47.93M 261.09M 266.44M 263.21M 264.02M 275.55M 277.29M 250.59M 250.31M 233.34M 232.75M 244.72M
Total Liabilities
267.35M 275.7M 307.39M 296.83M 297.95M 301.97M 317.57M 318.4M 296.59M 304.33M 301.61M 301.02M 377.77M
Total Debt
195.92M 190.9M 186.09M 181.5M 177.11M 172.92M 193.75M 191.22M 193.34M 190.94M 188.98M 187.07M 252.91M
Common Stock
1K 1K 1K 1K 24K 24K 24K 24K 13K 13K 11K 11K 9K
Retained Earnings
-1.22B -1.19B -971.37M -962.48M -953.1M -936.27M -955.41M -941.56M -894.88M -870.36M -849.79M -822.72M -799.86M
Comprehensive Income
875K 1.43M 717K 880K 719K 628K 2.09M 738K -568K -1.02M -1.56M -1.83M -1.73M
Shareholders Equity
-185.77M -157.96M 58.96M 67.87M 76.96M 93.62M 75.77M 87.91M 127.55M 151.14M 164.47M 190.48M 206.28M
Total Investments
n/a 255K 255K 255K 510K 255K 255K 255K n/a n/a n/a n/a n/a